AtaiBeckley (ATAI) Non Operating Income (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Non Operating Income of $1.1 million for Q1 2026, up 118.84% year-over-year from $511328.8 in Q1 2025, and up 118.84% quarter-over-quarter from -$5.9 million in Q1 2025.
AtaiBeckley (ATAI) Non Operating Income (2020 - 2026) Analysis & Trends
AtaiBeckley has reported Non Operating Income for 6 years, with the latest figure at -$32.5 million in Q3 2025.
- Quarterly Non Operating Income fell 742.55% year-over-year to -$32.5 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$49.8 million (down 130.8% YoY) and the FY2024 annual result came in at -$45.7 million, down 153.04% from the prior year.
- Non Operating Income for Q1 2026 stood at $1.1 million, up from -$5.9 million in the prior quarter.
- The five-year high for Non Operating Income was $1.1 million in Q1 2026, with the low at -$5.9 million in Q1 2025.
- A 5-year average of $443105.3 and a median of -$1.6 million in 2024 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income soared 1236.38% in 2023, then slumped 15466.67% in 2024.
- Over 5 years, Non Operating Income stood at -$3.4 million in 2021, then jumped by 48.41% to -$1.8 million in 2022, then surged by 967.94% to $15.2 million in 2023, then tumbled by 158.52% to -$8.9 million in 2024, then tumbled by 264.74% to -$32.5 million in 2025.
- According to Business Quant data, Non Operating Income over the past three periods registered -$32.5 million, -$2.4 million, and -$5.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | AtaiBeckley | 2.69 Bn | 2.69 Bn | - | -32.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.66 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Sep 30, 2025 | -32.53 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Mar 31, 2025 | -5.94 Mn |
| Mar 31, 2025 | -5.94 Mn |
| Dec 31, 2024 | -8.92 Mn |
| Sep 30, 2024 | -3.86 Mn |
| Jun 30, 2024 | -31.35 Mn |
| Mar 31, 2024 | -1.60 Mn |
| Dec 31, 2023 | 15.24 Mn |
| Sep 30, 2023 | 70.68 Mn |
| Jun 30, 2023 | 204,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Dec 31, 2022 | -1.76 Mn |
| Sep 30, 2022 | 5.29 Mn |
| Jun 30, 2022 | 4.55 Mn |
| Mar 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | -3.40 Mn |
| Sep 30, 2021 | 6.89 Mn |